查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1926889

居家医疗监测和诊断市场（按产品类型、监测模式、行动装置类型、连接方式、部署模式和最终用户划分）－2026-2032年全球预测

Home-Care Monitoring & Diagnostics Market by Product Type, Monitoring Mode, Portability, Connectivity, Deployment Model, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年居家医疗监测和诊断市场价值为 76.1 亿美元，预计到 2026 年将成长至 79.9 亿美元，预计到 2032 年将达到 117.2 亿美元，复合年增长率为 6.35%。

关键市场统计数据
基准年 2025 76.1亿美元
预计年份：2026年 79.9亿美元
预测年份 2032 117.2亿美元
复合年增长率 (%) 6.35%

简洁而引人入胜的引言阐述了智慧居家照护监测的迫切性，这种监测能够协调临床结果、患者自主性和系统效率。

居家照护监测和诊断技术正在重塑慢性病和急性病在传统临床环境之外的检测、管理和追踪方式。感测器设计、连接性和数据分析技术的进步，使临床医生能够在确保数据真实性和临床背景的同时，将护理服务延伸至患者家中。这种转变支持以后续观察为中心的模式，强调护理的连续性、及时干预和减少对间歇性就诊的依赖，同时为优先考虑基于价值的医疗结果的医疗系统和支付方提高运营效率。

对正在重新定义居家照护监测产品设计和临床整合的变革性技术、监管和护理服务转变进行权威评估

近年来，居家医疗监测和诊断领域发生了突破性变革，正在重塑产品开发重点、筹资策略和临床工作流程。首先，小型化和电池效率的提升使得设备能够从临床环境走向持久的家庭使用环境，从而扩展了连续监测和事件触发监测的范围。其次，无线连接和边缘运算技术的进步降低了延迟和本地资料处理的负担，使得即使在网路连接不稳定的情况下，也能实现更具弹性的解决方案。

对2025年关税调整对居家医疗监测设备相关人员的供应链、筹资策略和采购计画的影响进行重点分析

2025年的政策调整和贸易措施正对居家医疗监测医疗设备的供应链动态产生实际影响，迫使製造商和医疗系统重新调整其采购和生产策略。关税变化加剧了零件和成品到岸成本的波动，导致围绕近岸外包、供应商多元化和双重采购安排的讨论增多，以降低单一国家风险。这些讨论不仅限于财务层面，也影响整个价值链的设计决策、零件选择和供应商资格认证流程。

深度細項分析表明，产品类型、使用者环境、监控模式、便携性、连接性和部署模式如何决定临床和商业性路径。

细分市场洞察揭示了产品架构、用户场景、监测方法、便携性、连接性和部署模式如何共同影响居家医疗监测市场的临床效用和商业性差异化。按产品类型划分，该市场涵盖心臟监测系统、血糖监测系统、神经系统监测系统、呼吸监测系统、体温监测系统和生命征象监测系统。心电图监测进一步细分为心电图监视器、心臟事件记录器和心电图监测，而心电图解决方案又分为多通道和单通道。同时，血糖监测分为连续血糖监测仪和自我监测设备，后者进一步细分为间歇扫描式连续血糖监测和即时连续血糖监测。神经系统监测包括脑波监测仪和癫痫发作检测监视器，而呼吸监测则涵盖二氧化碳测量仪系统、呼吸频率监视器和肺计量计。体温监测包括电子体温计、耳体温计和额体温计，而生命征象系统包括血压计、电子秤、多功能监视器和脉动式血氧监测仪系统。

区域性策略意义：将基础建设、监管环境和支付方结构与全球市场的商业化和实施策略连结起来

区域趋势持续影响着整个地区居家照护监测和诊断技术的应用、监管预期和商业化策略。在美洲，完善的医疗保健基础设施、支付方积极参与基于价值的医疗模式以及成熟的分销网络，为注重互通性和上市后证据的整合监测解决方案创造了有利条件。北美医疗保健机构越来越倾向于选择能够与电子健康记录和护理管理平台整合的设备，并优先考虑那些能够降低再入院率和改善患者报告结局的解决方案。

关键的竞争动态和公司层面的挑战揭示了临床证据、平台整合和协作式市场推广模式如何塑造产业领导地位。

居家医疗监测和诊断领域的竞争地位取决于多种因素的综合作用，包括设备性能、平台互通性、临床证据和上市速度。主要企业正集中资源建构强大的生态系统，整合感测器、安全连接、分析功能和临床工作流程，从而提供端到端的解决方案，而非仅仅提供单一设备。投资长期临床研究和真实世界证据产生的企业，在争取纳入医疗服务路径以及与支付方协商报销条款时，将更具优势。

加强产品、供应链和商业化领域韧性、临床可靠性和综合医疗服务能力的实用建议

为了在居家照护监测和诊断领域实现永续价值，产业领导者应优先考虑兼顾近期部署和长期韧性的策略行动。首先，投资于模组化产品架构，以便针对不同的临床适应症和监管环境进行快速定制，从而在保持核心互通性的同时加速市场准入。其次，加强与供应商的关係，并考虑双重采购和区域製造伙伴关係，以降低政策引发的供应中断风险，并提高对需求波动的应对力。

采用透明的多方法调查方法，结合专家访谈、文献综述和情境分析，检验市场区隔和策略洞察。

本研究采用结构化、多维度的研究方法，确保研究结果和解读的准确性、相关性和透明度。研究人员从临床、监管、供应链和支付方等各领域的专家收集了主要定性数据，以阐明技术趋势和实施挑战的背景。此外，研究人员还利用同行评审文献、监管指导文件、临床标准和已发表的资料进行二次研究，检验新出现的主题并确保产品分类的有效性。对这些资讯来源进行三角验证，减少了研究偏差，并增强了所提出解读的可信度。

策略结论强调了製定综合性、循证解决方案和开展跨部门合作的必要性。

居家医疗监测和诊断技术的进步正朝着更深入的临床整合、更广泛的患者应用以及支持分散式医疗的先进平台生态系统发展。随着技术的整合和医疗模式的演变，那些能够将产品设计与临床工作流程相契合、确保资料管治并创造可验证成果的相关人员，将提供最具吸引力的价值提案。监管的清晰度和供应链的韧性之间的相互作用将继续影响产品上市时间和长期竞争力，而报销和基础设施方面的区域差异则需要製定个性化的商业化策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章居家医疗监测和诊断市场（按产品类型划分）

  • 心臟监测系统
    • 心电图监测仪
      • 多通道监视器
      • 单通道监视器
    • 心臟事件记录器
    • 心电图监测
  • 血糖监测系统
    • 连续血糖监测仪
      • 间歇扫描式动态血糖监测
      • 即时动态血糖监测
    • 自测血糖仪
  • 神经监测系统
    • 脑波监测仪
    • 癫痫发作侦测监测器
  • 呼吸监测系统
    • 二氧化碳测量仪系统
    • 呼吸频率监测器
    • 肺计量计
  • 体温监测系统
    • 数位体温计
    • 耳体温计
    • 额体温计
  • 生命征象监测系统
    • 血压监测仪
    • 电子秤
    • 多功能显示器
    • 脉动式血氧监测仪系统

第九章居家医疗监测与诊断市场（依监测模式划分）

  • 事件触发式监控
  • 即时监控
    • 持续监测
    • 间歇性监测

第十章 行动端居家医疗监测与诊断市场

  • 携带式装置
    • 手持显示器
    • 桌面显示器
  • 固定设备
  • 穿戴式装置
    • 补丁监视器
    • 智慧服装
    • 清单监视器

第十一章居家医疗监测和诊断市场：连结性和性别

  • 有线连接
    • 乙太网路
    • USB
  • 无线连线
    • Bluetooth
    • 细胞
    • Wi-Fi

第十二章居家医疗监测和诊断市场按部署模式划分

  • 基于云端的
    • 私有云端
    • 公共云端
  • 本地部署

第十三章居家医疗监测和诊断市场（按最终用户划分）

  • 居家医疗机构
  • 病人
    • 慢性疾病患者
    • 老年人
    • 復健护理
  • 远端医疗服务提供者
    • 院内监测
    • 第三人监控中心

第十四章 按地区分類的居家医疗监测和诊断市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章居家医疗监测与诊断市场（依群体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国居家医疗监测与诊断市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国居家医疗监测与诊断市场

第十八章：中国居家医疗监测与诊断市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • Garmin Ltd.
  • GE HealthCare Technologies Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Omron Healthcare Co., Ltd.
  • ResMed Inc.
  • Roche Diagnostics
Product Code: MRR-4F7A6D4FF35C

The Home-Care Monitoring & Diagnostics Market was valued at USD 7.61 billion in 2025 and is projected to grow to USD 7.99 billion in 2026, with a CAGR of 6.35%, reaching USD 11.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.61 billion
Estimated Year [2026] USD 7.99 billion
Forecast Year [2032] USD 11.72 billion
CAGR (%) 6.35%

A concise and compelling introduction that frames the urgent need for intelligent home-care monitoring, aligning clinical outcomes with patient autonomy and system efficiency

Home-care monitoring and diagnostics are reshaping how chronic and acute conditions are detected, managed, and followed up outside traditional clinical settings. Advances in sensor design, connectivity, and data analytics enable clinicians to extend the care continuum into patients' homes while preserving data fidelity and clinical context. This shift supports a patient-centered model that emphasizes continuous care, timely interventions, and reduced dependency on episodic hospital visits, and it creates operational efficiencies for health systems and payers that prioritize value-based outcomes.

As applications broaden, from cardiac rhythm surveillance to glucose sensing and respiratory assessment, stakeholders must navigate an evolving ecosystem of devices, platforms, and service models. Interoperability, regulatory clarity, and reimbursement alignment are emerging as critical enablers of scaled deployment. At the same time, patient acceptance hinges on ease of use, privacy assurances, and demonstrable improvements in quality of life. In this dynamic environment, this introduction outlines the fundamental tensions and opportunities that leaders must reconcile to realize the clinical and commercial potential of home-care monitoring and diagnostic solutions.

An authoritative assessment of the transformative technological, regulatory, and care delivery shifts that are redefining product design and clinical integration in home-care monitoring

Recent years have produced transformative shifts in the home-care monitoring and diagnostics landscape that are altering product development priorities, procurement strategies, and clinical workflows. First, miniaturization and improved battery efficiency have enabled devices to move from clinical settings into durable home use, thereby expanding the scope of continuous and event-triggered monitoring. Second, advances in wireless connectivity and edge computing have reduced latency and local data processing burdens, allowing for more resilient solutions that operate even with intermittent network availability.

Third, regulatory agencies have begun to provide clearer pathways for device approval and postmarket surveillance, which has accelerated commercial pathways while raising expectations for clinical evidence. Fourth, the rise of hybrid care models-combining telehealth with in-person care-has created new integration points where monitoring devices feed into remote care management platforms. Finally, a broader emphasis on patient experience and equity requires vendors to design for diverse user populations and to consider accessibility from the earliest stages of product design. Together, these trends are creating an environment in which rapid innovation coexists with heightened demands for reliability, security, and demonstrable clinical value.

A focused analysis of how 2025 tariff adjustments are reshaping supply chains, sourcing strategies, and procurement planning for home-care monitoring device stakeholders

Policy adjustments and trade actions in 2025 are exerting tangible effects on the supply chain dynamics for medical devices destined for home-care monitoring, prompting manufacturers and health systems to recalibrate sourcing and production strategies. Tariff changes have increased landed cost variability for components and finished goods, which in turn has fueled conversations about nearshoring, supplier diversification, and dual-sourcing arrangements to reduce exposure to single-country risks. These conversations are not merely financial; they influence design decisions, component selection, and vendor qualification processes across the value chain.

As firms respond, procurement timelines have lengthened in some cases while capital allocation decisions pivot toward supply chain resilience. Concurrently, the need to preserve device performance and regulatory compliance has limited the range of immediate substitutions for key components, creating pressure to invest in longer-term strategic partnerships with trusted suppliers. For clinical providers, these shifts have underscored the importance of transparent supplier information and lifecycle management to ensure continuity of patient monitoring services. In sum, tariff-driven dynamics in 2025 have accelerated supply chain modernization and strategic sourcing initiatives that are likely to persist beyond short-term policy cycles.

Deep segmentation insights showing how product type, user contexts, monitoring modes, portability, connectivity, and deployment models determine clinical and commercial pathways

Segment-level insights reveal how product architecture, user context, monitoring modality, portability, connectivity, and deployment model each shape clinical utility and commercial differentiation in the home-care monitoring market. Based on product type, the landscape spans cardiac monitoring systems, glucose monitoring systems, neurological monitoring systems, respiratory monitoring systems, temperature monitoring systems, and vital signs monitoring systems; cardiac monitoring further differentiates across ECG monitors, event monitors, and Holter monitors, with ECG solutions split into multi-channel and single-channel variants, while glucose monitoring divides into continuous glucose monitors and self-monitoring blood glucose devices, and continuous glucose monitoring further separates into intermittent scanning CGM and real-time CGM modalities. Neurological monitoring includes EEG monitors and seizure detection monitors, respiratory monitoring covers capnography systems, respiratory rate monitors, and spirometers, temperature monitoring encompasses digital, ear, and temporal thermometers, and vital signs systems include blood pressure monitors, digital weight scales, multiparameter monitors, and pulse oximeters.

Based on end user, differentiation arises across home healthcare agencies, patients, and telehealth service providers; patients themselves are segmented into chronic disease patients, elderly users, and post-acute care populations, while telehealth service provision bifurcates into hospital-based monitoring and third-party monitoring centers. In terms of monitoring mode, event-triggered solutions contrast with real-time monitoring, and real-time offerings further distinguish between continuous and intermittent monitoring approaches. Portability distinctions include portable devices, stationary devices, and wearable devices; portable solutions break down into handheld and tabletop monitors, and wearable devices encompass patch monitors, smart clothing, and wrist monitors. Connectivity modalities split between wired and wireless architectures, with wired options such as Ethernet and USB and wireless choices including Bluetooth, cellular, and Wi Fi. Finally, deployment model considerations separate cloud-based and on-premise implementations, with cloud environments differentiated into private and public configurations. These intersecting segmentation axes inform product requirements, clinical workflows, reimbursement pathways, and commercialization strategies.

Region-specific strategic implications that connect infrastructure readiness, regulatory environments, and payer landscapes to commercialization and adoption strategies across global markets

Regional dynamics continue to influence technology adoption, regulatory expectations, and commercialization strategies for home-care monitoring and diagnostics across large geographies. In the Americas, established healthcare infrastructure, active payer engagement with value-based models, and mature distribution networks create favorable conditions for integrated monitoring solutions that emphasize interoperability and postmarket evidence. North American providers increasingly seek devices that integrate with electronic health records and care management platforms, and they prioritize solutions that demonstrate improvements in readmission rates and patient-reported outcomes.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and diverse payer landscapes create both opportunities and complexities; European adoption is often driven by national reimbursement decisions and cross-border clinical collaborations, while emerging markets in the region place a premium on affordability, durability, and ease of deployment in resource-constrained settings. In the Asia-Pacific region, rapid device innovation is paired with large and heterogeneous patient populations, creating strong demand for scalable telehealth and remote monitoring services. Local manufacturing initiatives and strategic partnerships in Asia-Pacific also shape supply dynamics and may accelerate time-to-market for regionally optimized products. Understanding these regional nuances is essential for companies seeking to align product design, market entry strategy, and regulatory planning with local clinical and commercial realities.

Key competitive dynamics and company-level imperatives revealing how clinical evidence, platform integration, and collaborative go-to-market models shape industry leadership

Competitive positioning within the home-care monitoring and diagnostics space is determined by a combination of device performance, platform interoperability, clinical evidence, and go-to-market agility. Leading firms have concentrated resources on building robust ecosystems that integrate sensors, secure connectivity, analytics, and clinician-facing workflows, which enables them to deliver end-to-end solutions rather than standalone devices. Companies that invest in longitudinal clinical studies and real-world evidence generation have an advantage when seeking inclusion within care pathways and when negotiating reimbursement arrangements with payers.

Elsewhere, nimble entrants focus on niche clinical applications or underserved patient segments, using design simplicity and cost-efficiency to gain early adoption in home healthcare agencies and post-acute settings. Strategic partnerships between device manufacturers, telehealth providers, and software vendors are increasingly common, as collaborative models accelerate deployment and reduce the burden on clinical staff. Intellectual property around sensing modalities, data security, and user experience remains an important differentiator, but sustainable leadership also depends on operational excellence in supply chain management and regulatory compliance. For stakeholders evaluating potential partners, the critical question is whether a competitor can demonstrate not only superior technology but also the capability to support longitudinal care delivery at scale.

Actionable recommendations for leaders to strengthen resilience, clinical credibility, and integrated care delivery capabilities across product, supply chain, and commercialization domains

Industry leaders should prioritize strategic actions that balance near-term deployment with longer-term resilience to capture sustainable value in home-care monitoring and diagnostics. First, invest in modular product architectures that allow rapid customization for different clinical indications and regulatory jurisdictions, enabling faster market entry while preserving core interoperability. Second, strengthen supplier relationships and consider dual-sourcing or regional manufacturing partnerships to reduce exposure to policy-driven supply disruptions and to improve responsiveness to demand variability.

Third, commit to rigorous clinical evidence generation through multicenter studies and real-world data initiatives that validate clinical outcomes, patient adherence, and economic value from the perspective of payers and providers. Fourth, design privacy-by-default data architectures and pursue recognized security certifications to build trust among clinicians and patients. Fifth, cultivate partnerships with telehealth providers and care management platforms to embed monitoring into clinical workflows and to create integrated service offerings. Finally, align commercialization plans with regional regulatory strategies and reimbursement pathways to accelerate uptake. By executing these measures in concert, leaders can move beyond product-centric approaches toward comprehensive care enablement, thereby enhancing both clinical impact and commercial viability.

A transparent and multi-method research methodology that integrates expert interviews, literature review, and scenario analysis to validate segmentation and strategic findings

This research employed a structured, multi-method approach to ensure accuracy, relevance, and transparency in its findings and interpretations. Primary qualitative inputs were gathered from subject-matter experts across clinical, regulatory, supply chain, and payer functions to contextualize technology trends and deployment challenges. Secondary research drew on peer-reviewed literature, regulatory guidance documents, clinical standards, and public filings to corroborate emerging themes and to validate product categorizations. Triangulation across these sources reduced bias and strengthened confidence in the interpretations presented.

Analytical frameworks emphasized segmentation by product type, end user, monitoring mode, portability, connectivity, and deployment model, with crosswalks to regional regulatory and reimbursement contexts. Where appropriate, scenario-based analysis was used to explore how supply chain disruptions and policy changes might influence strategic choices. Quality assurance procedures included expert review cycles and consistency checks against publicly available clinical evidence. This methodology ensured that conclusions rest on a balanced synthesis of empirical evidence, practitioner insight, and strategic analysis, enabling readers to rely on the report for informed decision-making.

A strategic conclusion emphasizing the imperative for integrated evidence-driven solutions and cross-functional alignment to deliver meaningful clinical and patient outcomes

The trajectory of home-care monitoring and diagnostics points toward deeper clinical integration, broader patient adoption, and more sophisticated platform ecosystems that support distributed care. As technologies converge and care models evolve, stakeholders who align product design with clinical workflows, secure data governance, and demonstrable outcomes will create the most compelling value propositions. The interplay between regulatory clarity and supply chain resilience will continue to shape time-to-market and long-term competitiveness, while regional differences in reimbursement and infrastructure will require tailored commercialization strategies.

Ultimately, success in this domain depends on the ability to translate device capability into meaningful improvements in clinical decision-making and patient experience. Achieving that translation demands cross-functional collaboration across engineering, clinical affairs, regulatory, and commercial teams. Organizations that embrace integrated solutions, invest in evidence generation, and prioritize secure, patient-centered design will not only capture market opportunities but also contribute to a more responsive and equitable continuum of care for patients managed at home.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home-Care Monitoring & Diagnostics Market, by Product Type

  • 8.1. Cardiac Monitoring Systems
    • 8.1.1. ECG Monitors
      • 8.1.1.1. Multi Channel Monitors
      • 8.1.1.2. Single Channel Monitors
    • 8.1.2. Event Monitors
    • 8.1.3. Holter Monitors
  • 8.2. Glucose Monitoring Systems
    • 8.2.1. Continuous Glucose Monitors
      • 8.2.1.1. Intermittent Scanning CGM
      • 8.2.1.2. Real Time CGM
    • 8.2.2. Self Monitoring Blood Glucose Devices
  • 8.3. Neurological Monitoring Systems
    • 8.3.1. EEG Monitors
    • 8.3.2. Seizure Detection Monitors
  • 8.4. Respiratory Monitoring Systems
    • 8.4.1. Capnography Systems
    • 8.4.2. Respiratory Rate Monitors
    • 8.4.3. Spirometers
  • 8.5. Temperature Monitoring Systems
    • 8.5.1. Digital Thermometers
    • 8.5.2. Ear Thermometers
    • 8.5.3. Temporal Thermometers
  • 8.6. Vital Signs Monitoring Systems
    • 8.6.1. Blood Pressure Monitors
    • 8.6.2. Digital Weight Scales
    • 8.6.3. Multiparameter Monitors
    • 8.6.4. Pulse Oximeters

9. Home-Care Monitoring & Diagnostics Market, by Monitoring Mode

  • 9.1. Event Triggered Monitoring
  • 9.2. Real Time Monitoring
    • 9.2.1. Continuous Monitoring
    • 9.2.2. Intermittent Monitoring

10. Home-Care Monitoring & Diagnostics Market, by Portability

  • 10.1. Portable Devices
    • 10.1.1. Handheld Monitors
    • 10.1.2. Tabletop Monitors
  • 10.2. Stationary Devices
  • 10.3. Wearable Devices
    • 10.3.1. Patch Monitors
    • 10.3.2. Smart Clothing
    • 10.3.3. Wrist Monitors

11. Home-Care Monitoring & Diagnostics Market, by Connectivity

  • 11.1. Wired Connectivity
    • 11.1.1. Ethernet
    • 11.1.2. USB
  • 11.2. Wireless Connectivity
    • 11.2.1. Bluetooth
    • 11.2.2. Cellular
    • 11.2.3. Wi Fi

12. Home-Care Monitoring & Diagnostics Market, by Deployment Model

  • 12.1. Cloud Based
    • 12.1.1. Private Cloud
    • 12.1.2. Public Cloud
  • 12.2. On Premise

13. Home-Care Monitoring & Diagnostics Market, by End User

  • 13.1. Home Healthcare Agencies
  • 13.2. Patients
    • 13.2.1. Chronic Disease Patients
    • 13.2.2. Elderly
    • 13.2.3. Post Acute Care
  • 13.3. Telehealth Service Providers
    • 13.3.1. Hospital Based Monitoring
    • 13.3.2. Third Party Monitoring Centers

14. Home-Care Monitoring & Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Home-Care Monitoring & Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Home-Care Monitoring & Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Home-Care Monitoring & Diagnostics Market

18. China Home-Care Monitoring & Diagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Becton, Dickinson and Company
  • 19.7. Dexcom, Inc.
  • 19.8. Garmin Ltd.
  • 19.9. GE HealthCare Technologies Inc.
  • 19.10. iRhythm Technologies, Inc.
  • 19.11. Koninklijke Philips N.V.
  • 19.12. Masimo Corporation
  • 19.13. Medtronic plc
  • 19.14. Omron Healthcare Co., Ltd.
  • 19.15. ResMed Inc.
  • 19.16. Roche Diagnostics

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTI CHANNEL MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTI CHANNEL MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTI CHANNEL MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SINGLE CHANNEL MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SINGLE CHANNEL MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SINGLE CHANNEL MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOLTER MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOLTER MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME CGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME CGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME CGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EEG MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EEG MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EEG MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SEIZURE DETECTION MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SEIZURE DETECTION MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SEIZURE DETECTION MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY RATE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY RATE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY RATE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SPIROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SPIROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SPIROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EAR THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EAR THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EAR THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPORAL THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPORAL THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPORAL THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL WEIGHT SCALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL WEIGHT SCALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL WEIGHT SCALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT TRIGGERED MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT TRIGGERED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT TRIGGERED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HANDHELD MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HANDHELD MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HANDHELD MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TABLETOP MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TABLETOP MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TABLETOP MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY STATIONARY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY STATIONARY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATCH MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATCH MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATCH MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SMART CLOTHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SMART CLOTHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SMART CLOTHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WRIST MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WRIST MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WRIST MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ETHERNET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ETHERNET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ETHERNET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY USB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY USB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY USB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WI FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WI FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WI FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY POST ACUTE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY POST ACUTE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY POST ACUTE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY THIRD PARTY MONITORING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY THIRD PARTY MONITORING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY THIRD PARTY MONITORING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 256. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 258. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (